Aug 14, 2020
Alzheimer's Foundation of America Announces Virtual Professional Training Programs
Aug 11, 2020
The first Virtual Microscope of the human brain, developed by Darmiyan, accurately measures Alzheimer's-related abnormalities
Jun 18, 2020
uMETHOD Health Announces the Release of a Revolutionary Methodology to Help Prevent Alzheimer's Disease and Cognitive Decline
Jun 15, 2020
Elysium Health(TM) Announces the Launch of MATTER(TM)
Jun 04, 2020
AlzeCure Announces Positive Data From Clinical Study with ACD856
Jun 02, 2020
During Alzheimer's, Brain Awareness Month, Assisted Living Locators Encourages Families To Reassess Loved One's Dementia Care Situation
Jun 02, 2020
AstronauTx Announces an Alliance With Concept Life Sciences to Accelerate the Identification of Novel Therapies For Alzheimer's Disease
May 19, 2020
Results of GERAS-US Study Demonstrate Societal Cost Burden for Patients and Caregivers During Early Stages of Alzheimer's Disease
May 19, 2020
TauRx Reveals Study Results That Offers New Hope for Treatment of Patients With Dementia
Apr 29, 2020
Alzheimer's Drug Discovery Foundation's Diagnostics Accelerator Announces First Digital Biomarker Research Award and Data Sharing Platform
Apr 03, 2020
Axon Presented Positive Phase II Trial Results of AADvac1 at AAT-AD/PD 2020
Mar 24, 2020
Medical Care Corporation Achieves Phase I Milestone in Study to Detect Pre-Symptomatic Alzheimer's Disease
Mar 24, 2020
Okayama University Research: Novel Blood-based Markers to Detect Alzheimer's Disease
Mar 16, 2020
AlzeCure Pharma to Present Late Breaking Abstract at the AAT-AD/PD Conference (Advances in Alzheimer's and Parkinson's Therapies)
Mar 11, 2020
Primary Care Physicians on the Front Lines of Diagnosing and Providing Alzheimer's and Dementia Care: Half Say Medical Profession Not Prepared to Meet Expected Increase in Demands
Mar 06, 2020
New Roskamp Institute Clinical Research Shows Promise of Drug yo Slow Early-stage Alzheimer's Disease
Feb 12, 2020
Diagnomics Introduces HealthLytix Alzheimer's Disease Risk Assessments Through GenoMatch.Me Employee Benefits Program
Feb 11, 2020
T3D Therapeutics Begins Enrollment in the PIONEER Phase 2 Clinical Trial of T3D-959 in Patients with Mild to Moderate Alzheimer's Disease
Feb 10, 2020
New Alzheimer's Helpline Chat System Can Provide Care and Support in 90 Languages
Feb 10, 2020
Lilly Announces Topline Results for Solanezumab from the Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU) Study